Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer

References

• RenSXChengASToKFHost immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancerCancer Res201272246512652323100468
   PubMed Web of Science ®Google Scholar
• RenSXShenJChengASFK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cellsPLoS One201385e6364123700428
   PubMed Web of Science ®Google Scholar
• YangZZLiJQWangZZDongDWQiXRTumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomasBiomaterials201435195226523924695093
   PubMed Web of Science ®Google Scholar
• KimDHTermsarasabUChoHJPreparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxelInt J Nanomedicine201495711572725525355
   PubMed Web of Science ®Google Scholar
• ChuKSSchorzmanANFinnissMCNanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacyBiomaterials201334338424842923899444
   PubMed Web of Science ®Google Scholar
• GrecoFVicentMJCombination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicinesAdv Drug Deliv Rev200961131203121319699247
   PubMed Web of Science ®Google Scholar
• JinturkarKAAnishCKumarMKBagchiTPandaAKMisraARLiposomal formulations of etoposide and docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell linesBiomaterials20123382492250722200537
   PubMed Web of Science ®Google Scholar
• ZhouYYangJZhangRKopečekJCombination therapy of prostate cancer with HPMA copolymer conjugates containing PI3K/mTOR inhibitor and docetaxelEur J Pharm Biopharm20148910711525481033
   PubMedGoogle Scholar
• AwadaAAlbanellJCanneyPABortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation studyBr J Cancer20089891500150718454159
   PubMedGoogle Scholar
• SunLZhouDSZhangPLiQHLiuPGemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcomaInt J Pharm2014478130831725433201
   PubMed Web of Science ®Google Scholar
• PorcelliFVerardiRShiLHenzler-WildmanKARamamoorthyAVegliaGNMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micellesBiochemistry200847205565557218439024
   PubMedGoogle Scholar
• Henzler-WildmanKALeeDKRamamoorthyAMechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37Biochemistry200342216545655812767238
   PubMedGoogle Scholar
• Henzler-WildmanKAMartinezGVBrownMFRamamoorthyAPerturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37Biochemistry200443268459846915222757
   PubMedGoogle Scholar
• YanTDChuFLinksMKamPCGlennDMorrisDLCytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survivalEur J Surg Oncol200632101119112416887321
   PubMedGoogle Scholar
• HamidiMAzadiARafieiPHydrogel nanoparticles in drug deliveryAdv Drug Deliv Rev200860151638164918840488
   PubMed Web of Science ®Google Scholar
• ShimadaTNomuraMYokogawaKPharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in miceJ Pharm Pharmacol200557217718115720780
   PubMed Web of Science ®Google Scholar
• OzolsRFBookmanMAYoungRCIntraperitoneal chemotherapy for ovarian cancerN Engl J Med2006354151641164316611959
   PubMedGoogle Scholar
• BaeWKParkMSLeeJHDocetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancerBiomaterials20133441433144123174142
   PubMed Web of Science ®Google Scholar
• YonemuraYEndouYBandoEEffect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancerCancer Lett2004210218919615183534
   PubMedGoogle Scholar
• KehoeSMWilliamsNLYakubuRIncidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignanciesGynecol Oncol2009113222823219254808
   PubMedGoogle Scholar
• NazliCErgencTIYarYAcarHYKizilelSRGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cellsInt J Nanomedicine201271903192022619531
   PubMed Web of Science ®Google Scholar
• FanRDengXZhouLInjectable thermosensitive hydrogel composite with surface-functionalized calcium phosphate as raw materialsInt J Nanomedicine2014961562624489468
   PubMed Web of Science ®Google Scholar
• DeepaGThulasidasanAKAntoRJPillaiJJKumarGSCross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapyInt J Nanomedicine201274077408822888244
   PubMed Web of Science ®Google Scholar
• HoareTRKohaneDSHydrogels in drug delivery: progress and challengesPolymer200849819932007
   Web of Science ®Google Scholar
• QiuYParkKEnvironment-sensitive hydrogels for drug deliveryAdv Drug Deliv Rev200153332133911744175
   PubMed Web of Science ®Google Scholar
• IrvineDJDrug delivery: one nanoparticle, one killNat Mater201110534234321499312
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev200456111649165915350294
   PubMed Web of Science ®Google Scholar
• SinghRLillardJWJrNanoparticle-based targeted drug deliveryExp Mol Pathol200986321522319186176
   PubMed Web of Science ®Google Scholar
• TsaiMLuZWangJYehTKWientjesMGAuJLEffects of carrier on disposition and antitumor activity of intraperitoneal paclitaxelPharm Res20072491691170117447121
   PubMed Web of Science ®Google Scholar
• GalaupAOpolonPBouquetCCombined effects of docetaxel and angiostatin gene therapy in prostate tumor modelMol Ther20037673174012788646
   PubMedGoogle Scholar
• ChouTCTheoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studiesPharmacol Rev200658362168116968952
   PubMed Web of Science ®Google Scholar
• LinBRChangCCChenRJConnective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancerClin Cancer Res201117103077308821558398
   PubMed Web of Science ®Google Scholar
• MisraRSahooSKCoformulation of doxorubicin and curcumin in poly(d,l-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cellsMol Pharm20118385286621480667
   PubMed Web of Science ®Google Scholar
• YaoJLiYSunXDahmaniFZLiuHZhouJNanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acidInt J Nanomedicine201493313332425045262
   PubMed Web of Science ®Google Scholar
• VignoniMde Alwis WeerasekeraHSimpsonMJLL37 peptide@silver nanoparticles: combining the best of the two worlds for skin infection controlNanoscale20146115725572824789474
   PubMedGoogle Scholar
• ChuangCMMonieAWuAMaoCPHungCFTreatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancerHum Gene Ther200920430331319272013
   PubMedGoogle Scholar
• AnLLYangYHMaXTLL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6-1) DNA vaccineLeuk Res200529553554315755506
   PubMedGoogle Scholar
• ArmstrongDKBundyBWenzelLIntraperitoneal cisplatin and paclitaxel in ovarian cancerN Engl J Med20063541344316394300
   PubMed Web of Science ®Google Scholar
• WangLZhangMZhangNSynergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubesInt J Nanomedicine201162641265222114495
   PubMed Web of Science ®Google Scholar
• ConteCUngaroFMaglioGBiodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancerJ Control Release20131671405223298613
   PubMedGoogle Scholar